Loading company…
Tavotek develops large-molecule biologic medicines for cancer, autoimmune conditions, and infectious diseases.
Founded in 2019 and based in Suzhou, China, Tavotek develops large-molecule biopharmaceuticals. Its research platforms include phage display, tissue-specific biologics engineering, and multicyclic peptides. Its pipeline includes candidates for cancers, autoimmune conditions, and infectious diseases.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in